Goldman Sachs analyst Susan Maklari has maintained their bullish stance on DHI stock, giving a Buy rating on April 15.
Susan Maklari’s rating is based on D.R. Horton’s demonstrated ability to navigate challenging market conditions with a high degree of operational expertise. Factors that contribute to the Buy rating include the company’s consistent strategic approach, the advantages gained from its large scale, and the strength of its balance sheet. While acknowledging the potential for sustained high interest rates, Maklari is confident in the company’s capability to outperform its peers, particularly given its projected community count increase which is expected to drive revenue and margin growth.
Despite the near-term challenges that might be posed by the economic environment, Maklari maintains a positive outlook on D.R. Horton’s stock. This optimism is bolstered by the expectation that D.R. Horton will continue its effective execution of business strategies. Moreover, the anticipation of a 5% gain in community count in the coming years, compared to an average of 3% among the competition, sets the stage for potential upside to the company’s financial outcomes, should interest rates decline. Therefore, the combination of these elements supports the recommendation to Buy D.R. Horton shares.
In another report released on April 15, BTIG also maintained a Buy rating on the stock with a $169.00 price target.
TipRanks tracks over 100,000 company insiders, identifying the select few who excel in timing their transactions. By upgrading to TipRanks Premium, you will gain access to this exclusive data and discover crucial insights to guide your investment decisions. Begin your TipRanks Premium journey today.
DR Horton (DHI) Company Description:
Founded in 1978, Texas-based D.R. Horton, Inc. is a homebuilding company that is engaged in the construction and sale of single-family homes through its diverse brand portfolio that includes D.R. Horton, Emerald Homes, Express Homes and Freedom Homes.
